Cresco Labs Inc.
CRLBF
$0.90
-$0.05-5.22%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -8.71% | -8.16% | -8.27% | -11.14% | -8.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.71% | -8.16% | -8.27% | -11.14% | -8.78% |
| Cost of Revenue | -12.91% | -14.86% | -0.92% | -10.28% | -5.38% |
| Gross Profit | -4.05% | -0.84% | -15.07% | -11.93% | -12.26% |
| SG&A Expenses | -0.88% | 2.14% | -9.38% | -6.48% | 8.81% |
| Depreciation & Amortization | -4.60% | -9.00% | -1.16% | -14.82% | -4.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.90% | -8.23% | -4.24% | -8.96% | -0.25% |
| Operating Income | -17.78% | -7.63% | -29.55% | -21.53% | -53.40% |
| Income Before Tax | -204.36% | -2,952.60% | -189.22% | 106.70% | -105.76% |
| Income Tax Expenses | -0.67% | -31.12% | -37.59% | 62.50% | -20.48% |
| Earnings from Continuing Operations | -11.68% | -20,361.73% | -185.52% | 72.85% | -641.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 391.52% | 128.29% | 272.60% | 22.58% | 125.56% |
| Net Income | 9.42% | -1,903.39% | -61.79% | 69.94% | -177.91% |
| EBIT | -17.78% | -7.63% | -29.55% | -21.53% | -53.40% |
| EBITDA | -11.73% | -13.89% | -24.19% | -20.53% | -40.45% |
| EPS Basic | 12.86% | -1,831.75% | -58.42% | 70.73% | -171.05% |
| Normalized Basic EPS | 510.00% | 361.54% | 88.62% | 118.88% | -94.95% |
| EPS Diluted | 12.86% | -1,831.75% | -58.42% | 70.73% | -171.05% |
| Normalized Diluted EPS | 510.00% | 361.54% | 88.62% | 118.88% | -94.95% |
| Average Basic Shares Outstanding | 3.99% | 3.44% | 2.35% | 2.72% | 2.52% |
| Average Diluted Shares Outstanding | 3.99% | 3.44% | 2.35% | 2.72% | 2.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |